Scheda di dettaglio – i prodotti della ricerca

DatoValore
TitleAn integrated MBR-TiO2 photocatalysis process for the removal of Carbamazepine from simulated pharmaceutical industrial effluent
AbstractThis paper aims to demonstrate that integrating biological process and photocatalytic oxidation in a system operated in recycling mode can be a promising technology to treat pharmaceutical wastewater characterized by simultaneous presence of biodegradable and refractory/inhibitory compounds. A lab-scale system integrating a membrane bioreactor (MBR) and a TiO2 slurry photoreactor was fed on simulated wastewater containing 10 mg/L of the refractory drug Carbamazepine (CBZ). Majority of chemical oxygen demand (COD) was removed by the MBR, while the photocatalytic oxidation was capable to degrade CBZ. CBZ degradation kinetics and its impacts on the biological process were studied. The adoption of a recycling ratio of 4:1 resulted in removal of up to 95% of CBZ. Effluent COD reduction, sludge yield increase and respirometric tests suggested that the oxidation products were mostly biodegradable and not inhibiting the microbial activity. These results evidenced the advantages of the proposed approach for treating pharmaceutical wastewater and similar industrial effluents. (C) 2011 Elsevier Ltd. All rights reserved.
SourceBioresource technology 102 (13), pp. 7012–7015
KeywordsIntegrated processTitanium dioxideMembrane bioreactorCarbamazepine
JournalBioresource technology
EditorElsevier Applied Science,, Barking, Regno Unito
Year2011
TypeArticolo in rivista
DOI10.1016/j.biortech.2011.04.056
AuthorsLaera, G.; Chong, M. N.; Jin, Bo; Lopez, A.
Text42422 2011 10.1016/j.biortech.2011.04.056 ISI Web of Science WOS 000292487300034 Integrated process Titanium dioxide Membrane bioreactor Carbamazepine An integrated MBR TiO2 photocatalysis process for the removal of Carbamazepine from simulated pharmaceutical industrial effluent Laera, G.; Chong, M. N.; Jin, Bo; Lopez, A. CNR; CSIRO Land Water; Univ Adelaide; Univ Adelaide; SA Water Corp This paper aims to demonstrate that integrating biological process and photocatalytic oxidation in a system operated in recycling mode can be a promising technology to treat pharmaceutical wastewater characterized by simultaneous presence of biodegradable and refractory/inhibitory compounds. A lab scale system integrating a membrane bioreactor MBR and a TiO2 slurry photoreactor was fed on simulated wastewater containing 10 mg/L of the refractory drug Carbamazepine CBZ . Majority of chemical oxygen demand COD was removed by the MBR, while the photocatalytic oxidation was capable to degrade CBZ. CBZ degradation kinetics and its impacts on the biological process were studied. The adoption of a recycling ratio of 4 1 resulted in removal of up to 95% of CBZ. Effluent COD reduction, sludge yield increase and respirometric tests suggested that the oxidation products were mostly biodegradable and not inhibiting the microbial activity. These results evidenced the advantages of the proposed approach for treating pharmaceutical wastewater and similar industrial effluents. C 2011 Elsevier Ltd. All rights reserved. 102 Published version http //www.scopus.com/record/display.url eid=2 s2.0 79956342847 origin=inward Articolo in rivista Elsevier Applied Science, 0960 8524 Bioresource technology Bioresource technology Bioresour. technol. Bioresource technology. giuseppe.laera LAERA GIUSEPPE antonio.lopez LOPEZ ANTONIO TA.P07.002.004 Processi biotecnologici e processi a membrana